On 2025-08-11, Cadrenal Therapeutics, Inc. (CVKD) announced earnings per share of $-1.87 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-1.60.
The next expected annoucement date for quarterly earnings is 2025-11-06, with an average estimated earnings per share of $-1.56 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-11 | 2025-06-30 | $-1.60 | $-1.87 |
| 2025-05-08 | 2025-03-31 | $-1.64 | $-2.09 |
| 2025-03-13 | 2024-12-31 | $-1.71 | $-2.74 |
| 2024-11-07 | 2024-09-30 | $-1.83 | $-2.18 |
| 2024-08-07 | 2024-06-30 | $-19.04 | $-2.25 |
| 2024-05-09 | 2024-03-31 | $-1.05 | $-1.50 |
| 2024-03-11 | 2023-12-31 | $-1.35 | $-0.75 |
| 2023-11-09 | 2023-09-30 | -- | $-1.05 |
| 2023-08-10 | 2023-06-30 | -- | $-1.35 |
| 2023-05-10 | 2023-03-31 | -- | $-6.15 |